248 related articles for article (PubMed ID: 15837137)
1. Platelet-derived growth factor (PDGF-BB) and brain-derived neurotrophic factor (BDNF) induce striatal neurogenesis in adult rats with 6-hydroxydopamine lesions.
Mohapel P; Frielingsdorf H; Häggblad J; Zachrisson O; Brundin P
Neuroscience; 2005; 132(3):767-76. PubMed ID: 15837137
[TBL] [Abstract][Full Text] [Related]
2. Increased progenitor cell proliferation and astrogenesis in the partial progressive 6-hydroxydopamine model of Parkinson's disease.
Aponso PM; Faull RL; Connor B
Neuroscience; 2008 Feb; 151(4):1142-53. PubMed ID: 18201835
[TBL] [Abstract][Full Text] [Related]
3. Endogenous brain-derived neurotrophic factor protects dopaminergic nigral neurons against transneuronal degeneration induced by striatal excitotoxic injury.
Canudas AM; Pezzi S; Canals JM; Pallàs M; Alberch J
Brain Res Mol Brain Res; 2005 Mar; 134(1):147-54. PubMed ID: 15790538
[TBL] [Abstract][Full Text] [Related]
4. Dissociation between short-term increased graft survival and long-term functional improvements in Parkinsonian rats overexpressing glial cell line-derived neurotrophic factor.
Georgievska B; Carlsson T; Lacar B; Winkler C; Kirik D
Eur J Neurosci; 2004 Dec; 20(11):3121-30. PubMed ID: 15579166
[TBL] [Abstract][Full Text] [Related]
5. Delayed gene therapy of glial cell line-derived neurotrophic factor is efficacious in a rat model of Parkinson's disease.
Zheng JS; Tang LL; Zheng SS; Zhan RY; Zhou YQ; Goudreau J; Kaufman D; Chen AF
Brain Res Mol Brain Res; 2005 Mar; 134(1):155-61. PubMed ID: 15790539
[TBL] [Abstract][Full Text] [Related]
6. Neurorescue effects of VEGF on a rat model of Parkinson's disease.
Yasuhara T; Shingo T; Muraoka K; Kameda M; Agari T; Wen Ji Y; Hayase H; Hamada H; Borlongan CV; Date I
Brain Res; 2005 Aug; 1053(1-2):10-8. PubMed ID: 16045899
[TBL] [Abstract][Full Text] [Related]
7. Striatal carotid body graft promotes differentiation of neural progenitor cells into neurons in the olfactory bulb of adult hemiparkisonian rats.
Belzunegui S; Izal-Azcárate A; San Sebastián W; Garrido-Gil P; Vázquez-Claverie M; López B; Marcilla I; Luquin MR
Brain Res; 2008 Jun; 1217():213-20. PubMed ID: 18502401
[TBL] [Abstract][Full Text] [Related]
8. Exercise exerts neuroprotective effects on Parkinson's disease model of rats.
Tajiri N; Yasuhara T; Shingo T; Kondo A; Yuan W; Kadota T; Wang F; Baba T; Tayra JT; Morimoto T; Jing M; Kikuchi Y; Kuramoto S; Agari T; Miyoshi Y; Fujino H; Obata F; Takeda I; Furuta T; Date I
Brain Res; 2010 Jan; 1310():200-7. PubMed ID: 19900418
[TBL] [Abstract][Full Text] [Related]
9. Progenitor proliferation in the adult hippocampus and substantia nigra induced by glial cell line-derived neurotrophic factor.
Chen Y; Ai Y; Slevin JR; Maley BE; Gash DM
Exp Neurol; 2005 Nov; 196(1):87-95. PubMed ID: 16112112
[TBL] [Abstract][Full Text] [Related]
10. Intrastriatal administration of human immunodeficiency virus-1 glycoprotein 120 reduces glial cell-line derived neurotrophic factor levels and causes apoptosis in the substantia nigra.
Nosheny RL; Bachis A; Aden SA; De Bernardi MA; Mocchetti I
J Neurobiol; 2006 Oct; 66(12):1311-21. PubMed ID: 16967504
[TBL] [Abstract][Full Text] [Related]
11. 1,25-Dihydroxyvitamin D3 administration to 6-hydroxydopamine-lesioned rats increases glial cell line-derived neurotrophic factor and partially restores tyrosine hydroxylase expression in substantia nigra and striatum.
Sanchez B; Relova JL; Gallego R; Ben-Batalla I; Perez-Fernandez R
J Neurosci Res; 2009 Feb; 87(3):723-32. PubMed ID: 18816795
[TBL] [Abstract][Full Text] [Related]
12. Quantitative analysis of the generation of different striatal neuronal subtypes in the adult brain following excitotoxic injury.
Collin T; Arvidsson A; Kokaia Z; Lindvall O
Exp Neurol; 2005 Sep; 195(1):71-80. PubMed ID: 15936016
[TBL] [Abstract][Full Text] [Related]
13. NMDA receptors mediate an early up-regulation of brain-derived neurotrophic factor expression in substantia nigra in a rat model of presymptomatic Parkinson's disease.
Bustos G; Abarca J; Bustos V; Riquelme E; Noriega V; Moya C; Campusano J
J Neurosci Res; 2009 Aug; 87(10):2308-18. PubMed ID: 19326433
[TBL] [Abstract][Full Text] [Related]
14. Continuous exposure to glial cell line-derived neurotrophic factor to mature dopaminergic transplants impairs the graft's ability to improve spontaneous motor behavior in parkinsonian rats.
Winkler C; Georgievska B; Carlsson T; Lacar B; Kirik D
Neuroscience; 2006 Aug; 141(1):521-31. PubMed ID: 16697115
[TBL] [Abstract][Full Text] [Related]
15. Tyrosine hydroxylase cells appearing in the mouse striatum after dopamine denervation are likely to be projection neurones regulated by L-DOPA.
Darmopil S; Muñetón-Gómez VC; de Ceballos ML; Bernson M; Moratalla R
Eur J Neurosci; 2008 Feb; 27(3):580-92. PubMed ID: 18279311
[TBL] [Abstract][Full Text] [Related]
16. Intrastriatal infusions of brain-derived neurotrophic factor: retrograde transport and colocalization with dopamine containing substantia nigra neurons in rat.
Mufson EJ; Kroin JS; Sobreviela T; Burke MA; Kordower JH; Penn RD; Miller JA
Exp Neurol; 1994 Sep; 129(1):15-26. PubMed ID: 7523178
[TBL] [Abstract][Full Text] [Related]
17. Influences of dopaminergic lesion on epidermal growth factor-ErbB signals in Parkinson's disease and its model: neurotrophic implication in nigrostriatal neurons.
Iwakura Y; Piao YS; Mizuno M; Takei N; Kakita A; Takahashi H; Nawa H
J Neurochem; 2005 May; 93(4):974-83. PubMed ID: 15857400
[TBL] [Abstract][Full Text] [Related]
18. AAV-mediated delivery of BDNF augments neurogenesis in the normal and quinolinic acid-lesioned adult rat brain.
Henry RA; Hughes SM; Connor B
Eur J Neurosci; 2007 Jun; 25(12):3513-25. PubMed ID: 17610571
[TBL] [Abstract][Full Text] [Related]
19. Cytoprotective effects of growth factors: BDNF more potent than GDNF in an organotypic culture model of Parkinson's disease.
Stahl K; Mylonakou MN; Skare Ø; Amiry-Moghaddam M; Torp R
Brain Res; 2011 Mar; 1378():105-18. PubMed ID: 21236244
[TBL] [Abstract][Full Text] [Related]
20. Effect of AdGDNF on dopaminergic neurotransmission in the striatum of 6-OHDA-treated rats.
Smith AD; Kozlowski DA; Bohn MC; Zigmond MJ
Exp Neurol; 2005 Jun; 193(2):420-6. PubMed ID: 15869944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
